Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. AAPL
4. CHYM
5. USO
6. QCOM
7. IRT
8. ASO
9. LAES
10. UNFI

Go back to Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6
(NASDAQ: INTS) Delayed: 4.05 -0.04 (0.98%)
Previous Close $4.09    52 Week High $ 
Open $4.12    52 Week Low $ 
Day High $4.12    P/E N/A 
Day Low $3.99    EPS $ 
Volume 4,263